NLM Digital Collections

Search

Start Over Authors Chapman, Rick M., author ✖Remove constraint Authors: Chapman, Rick M., author Publication Year 2019 ✖Remove constraint Publication Year: <span class="single" data-blrl-single="2019">2019</span>

1. Alirocumab for treatment of high cholesterol: effectiveness and value : new evidence update

Author(s):
Tice, Jeffrey A., author
Chapman, Rick M., author
Rind, David M., author
Pearson, Steven D., author
Kazi, Dhruv S., author
Coxson, Pamela G., author
Penko, Joanne, author
Bibbins-Domingo, Kristen, author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, February 15, 2019
Subject(s):
Hypercholesterolemia -- drug therapy
Proprotein Convertase 9
United States

2. Oral immunotherapy and Viaskin Peanut for peanut allergy: effectiveness and value : final evidence report

Author(s):
Tice, Jeffrey A., author
Herron-Smith, Serina, author
Tsiao, Emily, author
Chapman, Rick M., author
Zaim, Remziye, author
Segel, Celia, author
Rind, David, author
Pearson, Steven D., author
Guzauskas, Greg, author
Hansen, Ryan N., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, July 10, 2019
Subject(s):
Immunotherapy
Peanut Hypersensitivity
United States

3. Siponimod for the treatment of secondary progressive multiple sclerosis: effectiveness and value : final evidence report

Author(s):
Sharaf, Ravi, author
Synnott, Patricia, author
Samur, Sumeyye, author
Chapman, Rick M., author
Adair, Ellie, author
Rind, David, author
Pearson, Steve, author
O'Grady, Madeline, author
Bloudek, Lisa, author
Carlson, Josh J., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, June 20, 2019
Subject(s):
Multiple Sclerosis, Chronic Progressive -- drug therapy
Sphingosine 1 Phosphate Receptor Modulators
United States